NEW YORK (GenomeWeb News) – Affymetrix today said that it anticipates revenues of $80 million for the third quarter, below the average consensus analyst expectation of $84.6 million.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.
A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.
Researchers report that paternally inherited genes are more likely to be expressed in mice.
The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.